You Position: Home > Journal Detail
All Issues
2024:
2023:
2022:
2021:
2020:
2019:
2018:
2017:
2016:
2015:
2014:
2013:
2012:
2011:
2010:
2009:
2008:
2007:
2006:
2005:
2004:
2003:
2002:
2001:
2000:
1999:
1998:
本刊主要是及时报道我国在肿瘤防治研究领域包括癌症基础理论研究和癌症预防、临床治疗研究方面的新进展、新成果，内容涉及肿瘤病因学与浒病学，实验肿瘤学、肿瘤细胞分子生物学，肿瘤病理学以及肿瘤影像诊断、肿瘤外科治疗、化学治疗、放射治疗、介入治疗、生物治疗和中西医结合治疗肿瘤等各分支学科，旨在促进国内外学术交流，提高我国癌症研究与癌症治疗水平。
- 1: Molecular features of gastroenteropancreatic neuroendocrine carcinoma:A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas (Jianwei Zhang Hanxiao Chen Junli Zhang Sha Wang Yanfang Guan Wenguang Gu Jie Li Xiaotian Zhang Jian Li Xicheng Wang Zhihao Lu Jun Zhou Zhi Peng Yu Sun Yang Shao Lin Shen Minglei Zhuo Ming Lu)
- 2: Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer:A retrospective study (Changsong Qi Xiaoyi Chong Ting Zhou Mingyang Ma Jifang Gong Miao Zhang Jian Li Jun Xiao Xiaohui Peng Zhen Liu Zonghai Li Lin Shen Xiaotian Zhang)
- 3: Microbiota in colorectal cancer related to liver metastasis (Peijun Wei Weiming Han Zitong Zhang Xue Tian Chen Yang Qiaoxuan Wang Weihao Xie Ying Liu Yuanhong Gao Hui Chang)
- 4: A phase Ⅰ study of Hemay022,an irreversible dual EGFR/HER2 tyrosine kinase inhibitor in Chinese patients with HER2-positive advanced breast cancer (Pin Zhang Lin Wang Yueying Zhen Zhihong Wang Hesheng Zhang Richard Jones Binghe Xu)
- 5: Plant-based dietary patterns and risk of esophageal cancer:A prospective cohort study spanning 17 years (Xiaorui Zhang Feifan He Jiayue Li Ru Chen Xinqing Li Li Li Fen Liu Shaoming Wang Wenqiang Wei)
- 6: Risk stratification for radioactive iodine refractoriness using molecular alterations in distant metastatic differentiated thyroid cancer (Zhuanzhuan Mu Xin Zhang Dongquan Liang Jugao Fang Ge Chen Wenting Guo Di Sun Yuqing Sun Zhentian Kai Lisha Huang Jun Liang Yansong Lin)
- 7: Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer:A phase Ⅱ single-arm study (Yaping Yang Liang Jin Yudong Li Nanyan Rao Chang Gong Shunrong Li Jiannan Wu Jinghua Zhao Linxiaoxiao Ding Fengxia Gan Jun Zhang Ruifa Feng Zhenzhen Liu Qiang Liu)
- 8: Genomic characterization of peritoneal lavage cytology-positive gastric cancer (Zhouqiao Wu Tingfei Gu Changxian Xiong Jinyao Shi Jingpu Wang Ting Guo Xiaofang Xing Fei Pang Ning He Rulin Miao Fei Shan Yuan Zhou Ziyu Li Jiafu Ji)
- 9: Manufacturing CAR-NK against tumors:Who is the ideal supplier? (Feifei Guo Yi Zhang Jiuwei Cui)